(Source: Foraco International).
  • Foraco International announced the completion of the sale of its shareholding in its subsidiary, EDC Russia
  • The global provider of mineral and water drilling services announced its definitive exit from Russia, with the sale of its shareholding in EDC Russia, a transaction that has received approval from the Russian authorities
  • EDC contributions to Foraco’s consolidated revenues were US$3.8 million and US$3.5 million respectively in Q1 and Q2 2023, for a net income close to nil for the first half of 2023
  • Foraco International stock opened trading at C$2.87 per share

Foraco International (TSX:FAR) announced the completion of the sale of its shareholding in its subsidiary, EDC Russia.

The global provider of mineral and water drilling services announced its definitive exit from Russia, with the sale of its shareholding in EDC Russia, a transaction that has received approval from the Russian authorities. This deal results in a marginal net profit for the company.

On April 5 2023, the company entered into a preliminary agreement to sell its 50 per cent stake in the subsidiary to its Russian partners.

According to its unaudited condensed interim consolidated financial statements for the three‐ and six‐month periods ending June 30, 2023, EDC contributions to Foraco’s consolidated revenues were US$3.8 million and US$3.5 million respectively in Q1 and Q2 2023, for a net income close to nil for the first half of 2023.

Based in Marseille, France, Foraco International is the third largest global mineral driller providing innovative solutions for mining and water projects across 22 countries and five continents.

Foraco International stock chart – March 2023 to March 2024.

Foraco International SA stock opened trading at C$2.87 per share and has risen 59.44 per cent since this time last year.

Join the discussion: Find out what everybody’s saying about this stock on the Foraco International SA Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online

Oncolytics Biotech approved to expand pancreatic cancer program

Oncolytics Biotech, a cancer immunotherapy stock, receives ethics and German regulatory approvals for a new pancreatic cancer study.

ESE producing championship e-sports tournament for Riot Games

ESE Entertainment’s (TSXV:ESE) media production unit, Frenzy, takes on the distribution of the upcoming Teamfight Tactics e-sports tournament.

4 stocks to consider after Microsoft’s 2024 study on AI at work

Microsoft (NASDAQ:MSFT) on Wednesday released the 2024 Work Trend Index, which looks into the state of artificial intelligence at work.

Buzz on the Bullboards: Who benefits from the latest stock market rally?

Investors are eagerly anticipating top corporate earnings this week, seeking further insights into market trends and potential opportunities.